MedTrace Logo

Effect of a Topical Cetylated Fatty Acid Cream on Pain Relief in Patients With Knee Osteoarthritis

NCT07745387 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 156

Last updated 2026-08-04

No results posted yet for this study

Summary

This multicenter, randomized, double-blind, placebo-controlled study is designed to evaluate the efficacy and safety of Cetilar® cream in adults with osteoarthritis-related knee pain. The study will assess the effects of treatment on knee pain, physical function, use of rescue medication, quality of life, and safety outcomes.

Conditions

  • Knee Osteoarthristis

Interventions

OTHER

Cetilar® Cream

Topical cream containing cetylated fatty acids. The cream will be applied to the affected knee twice daily for 30 days.

OTHER

Placebo cream

Matching placebo cream applied to the affected knee twice daily for 30 days.

Sponsors & Collaborators

  • Pharmanutra S.p.a.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-24
Primary Completion
2024-11-20
Completion
2024-11-20

Countries

  • Georgia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07745387 on ClinicalTrials.gov